| abstract |
MODIFIED TRANSFERRIN FUSION PROTEINS Abstract Modified fusion proteins of transferrin and therapeutic proteins or peptides including soluble toxin 5 receptors, with increased serum half-life or serum stability are disclosed. Preferred fusion proteins include those modified so that the transferrin moiety exhibits no or reduced glycosylation, binding to iron and/or binding to the transferrin receptor. |